Professor Amanj Kurdi
Strathclyde Institute of Pharmacy and Biomedical Sciences
Personal statement
Professor Amanj Kurdi is Professor of Pharmacoepidemiology and Pharmacy Practice at the University of Strathclyde. His research focuses on the generation and application of real world evidence to evaluate the utilisation, effectiveness, safety, and value of medicines and healthcare interventions, with the aim of informing clinical practice, health policy, and regulatory decision making.
His work spans pharmacoepidemiology, drug utilisation research, medicines optimisation, medication safety, antimicrobial stewardship, and health services research. He has extensive expertise in the analysis of large-scale routinely collected healthcare data, including linked electronic health records, prescribing databases, hospital datasets, and national population-level resources. Using advanced epidemiological, statistical, and data science methods, his research examines prescribing quality, medication adherence and persistence, treatment outcomes, and the impact of health policies and clinical guidelines across a range of therapeutic areas.
Professor Kurdi has particular interests in antimicrobial resistance (AMR), antimicrobial stewardship, cardiovascular disease, diabetes, biologics and specialist medicines, and the use of real world data to support post-marketing surveillance and medicines safety monitoring. He leads and collaborates on national and international projects involving big data analytics, health informatics, and population health research, working closely with healthcare providers, policymakers, regulators, and academic partners.
He actively collaborates with researchers and institutions across the UK and internationally and contributes to several multidisciplinary research networks and initiatives. Through his research, he aims to improve the quality, safety, and sustainability of healthcare while strengthening the evidence base that supports medicines use and health policy decisions.
Prize And Awards
- Honorary Professor
- Recipient
- 1/6/2026
- External Examiner
- Recipient
- 24/2/2025
- Top-ranked research paper in the Seventh Excellent Paper Symposium (1st Position)
- Recipient
- 16/11/2024
- Honorary Reader in Pharmacoepidemiology and Pharmacy Practice, NHS Lanarkshire, Scotland.
- Recipient
- 1/3/2024
- Best Researcher (Poster winner)
- Recipient
- 11/2/2024
- Reproducibility Recognition by HDR UK as a member of EAVE II – Early Pandemic Evaluation and Enhanced Surveillance of COVID-19
- Recipient
- 31/1/2024
Publications
- Sociodemographic, health and criminological risk factors for post-imprisonment mental health and substance use-related service contacts : a nationwide retrospective cohort study using linked data (RELEASE)
- Kjellgren Richard, Savinc Jan, Dougall Nadine, Watson Jim, Brown Ashley, Parkes Tessa, Kurdi Amanj, Leyland Alastair, Haddow Christine, Hunt Kate, Connell Catriona
- Social Psychiatry and Psychiatric Epidemiology (2026)
- https://doi.org/10.1007/s00127-026-03217-x
- Data Resource profile : Medicines in Acute and Chronic Care in Scotland (MACCS)
- Goswami Cosmika, Mueller Tanja, Kurdi Amanj, Pearson Ewan, Bedir Khaled, Tolfrey Alexandra, Close Hazel, Bennie Marion
- International Journal of Epidemiology Vol 55 (2026)
- https://doi.org/10.1093/ije/dyag187
- Budget impact analysis of subcutaneous infliximab (ct-p13 sc) for treating autoimmune diseases in Jordan
- Mousa Rimal, Halloush Shiraz, Radaydeh Farah, Al Yami Majed, Melhem Samar, Kurdi Amanj, Alkhatib Nimer
- Cost Effectiveness and Resource Allocation (2026)
- Opioid utilisation and their associated mortality in Northern Ireland
- Kurdi Amanj
- The 42nd ICPE Annual Meeting (2026)
- Profiling the pattern of medication use during pregnancy : an international scoping review of observational studies
- Parvin Irin, Abunimeh Hanan, Alshammari Hisham, Kurdi Amanj, Bennie Marion, Mueller Tanja
- Expert Review of Clinical Pharmacology Vol 19, pp. 729-747 (2026)
- https://doi.org/10.1080/17512433.2026.2710151
- How are antipsychotics used in acute hospital care : real-world evidence on high-dose antipsychotic prescribing from a population-based study in Scotland
- Goswami Cosmika, Mueller Tanja, Wall Alexa, Johnson Chris, Grosset David, Bennie Marion, Kurdi Amanj
- International Society of Pharmacoepidemiology (2026)
Professional Activities
- The International Conference on Real World Evidence (RWE) 2026
- Speaker
- 12/8/2026
- NHS Lanarkshire Research Masterclass 5 (Academic Writing)
- Organiser
- 17/6/2026
- NHS Lanarkshire Research Masterclass 4 (Data Analysis)
- Organiser
- 27/5/2026
- NHS Lanarkshire Research Masterclass 3 (Funding)
- Organiser
- 29/4/2026
- NHS Lanarkshire Research Masterclass 2 (Protocol Development)
- Organiser
- 11/3/2026
- Cross-Faculty Connections: Growing Networks and Building Opportunities with and for Children and Young People
- Participant
- 26/2/2026
Projects
- Enhancing Real-World Data Analysis Skills through Transnational Education: Bridging Global Health Knowledge and Practical Applications
- Kurdi, Amanj (Principal Investigator)
- 01-Jan-2026 - 31-Jan-2027
- MHRA – Scottish Collaboration Proposal to Pilot Next-Generation Medication Surveillance and Pharmacovigilance
- Bennie, Marion (Principal Investigator) Kurdi, Amanj (Co-investigator) Mueller, Tanja (Co-investigator)
- 01-Jan-2025 - 30-Jan-2026
- Tackling antimicrobial resistance in Saudi Arabia: a multidisciplinary program to instigating evidence-based, theory-driven antimicrobial stewardship interventions using mixed-method approach
- Elrggal, Mahmoud (CoPI) Kurdi, Amanj (Principal Investigator)
- A 48 months project funded by The Saudi Basic Science Initiative, Research Development and Innovation Authority (RDIA), ~£300K
- 01-Jan-2025 - 30-Jan-2029
- Real world effectiveness of Tirzepatide, Semaglutide, and Liraglutide effects on Lipid Profile, Blood Pressure, body weight, HbA1c and heart rate among diabetic and non-diabetic patients: A Systematic Review and meta-analysis of Observational Studies
- Alotaibi, Eman (Principal Investigator) Kurdi, Amanj (Principal Investigator) Alotaibi, Badriah (Academic)
- 01-Jan-2024 - 30-Jan-2025
- Cancer Medicines Outcomes Programme - Public Health Scotland
- Vettini, Amanda (Researcher) Dunlop, Emma (Co-investigator) Mueller, Tanja (Co-investigator) Bennie, Marion (Principal Investigator) Kurdi, Amanj (Co-investigator) Lu, Liya (Researcher)
- The aim of CMOP-PHS is to better understand the real world outcomes of cancer medicines for cancer patients in Scotland. The project is a collaboration between the University of Strathclyde, Public Health Scotland and the NHS Health Boards.
- 01-Jan-2024 - 31-Jan-2027
- Cancer Medicines Outcomes Programme - Public Health Scotland
- Dunlop, Emma (Co-investigator) Mueller, Tanja (Co-investigator) Bennie, Marion (Principal Investigator) Kurdi, Amanj (Co-investigator) Lu, Liya (Researcher) Kavanagh, Kimberley (Co-investigator)
- The aim of CMOP-PHS is to better understand the real world outcomes of cancer medicines for cancer patients in Scotland. The project is a collaboration between the University of Strathclyde, Public Health Scotland and the NHS Health Boards.
- 01-Jan-2024 - 31-Jan-2027
Contact
Professor
Amanj
Kurdi
Strathclyde Institute of Pharmacy and Biomedical Sciences
Email: amanj.baker@strath.ac.uk
Tel: 548 2181